Mupirocin Infectopharm

Mupirocin, the active ingredient in Mupirocin Infectopharm, is a topical antibiotic presented as a topical ointment for skin use. It treats bacterial skin infections such as impetigo, secondary bacterial skin infections, and infected minor wounds in patients of all ages.

GNH USA supplies Mupirocin Infectopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibiotic used to manage bacterial skin infections.

Impetigo: reduces bacterial load and promotes healing of infected lesions. Secondary bacterial skin infections: eradicates susceptible organisms and limits spread. Infected minor wounds: prevents colonisation and supports tissue repair.

Mupirocin may cause local skin reactions.

Common Side Effects: - Mild irritation or burning at the application site. - Itching or pruritus. - Redness or erythema. - Dry or flaky skin. - Mild pain or tenderness. - Slight swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin necrosis. - Systemic hypersensitivity reactions. - Stevens‑Johnson syndrome (rare). - Anaphylaxis (very rare). - Significant edema or ulceration.

Before using Mupirocin, consider the following precautions.

Apply only to intact skin or minor wounds: avoid use on large, deep or severely damaged areas. Known hypersensitivity: do not use if the patient has a documented allergy to mupirocin or related compounds. Concurrent topical agents: avoid mixing with other ointments unless directed by a clinician. Duration of therapy: limit use to the period prescribed, typically not exceeding 10 days. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mupirocin has limited systemic interactions, but caution is advised with certain topical agents.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics containing similar agents: risk of additive toxicity. - Use with systemic antibiotics that may mask infection progression: may delay recognition of treatment failure.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams: may increase local irritation. - Use with antiseptic‑containing dressings: possible reduction in mupirocin efficacy. - Combination with retinoid preparations: monitor for heightened skin sensitivity.